ADAP
Adaptimmune Therapeutics
ADAP
ADAP
46 hedge funds and large institutions have $219M invested in Adaptimmune Therapeutics in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 8 closing their positions.
Holders
46
Holders Change
-1
Holders Change %
-2.13%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
8
Increased
11
Reduced
11
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–